Further studies found that SOX2 expression was higher in tumor cells with relatively low sensitivity to radiotherapy, for example, in prostate cancer, SOX2 expression was upregulated in tumor cells that survived fractionated radiotherapy 35. This evidence concerns the gene SOX2 and prostate carcinoma.